Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Bros. Advisors (gp) Llc
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   608,718    

Indirect Shares

   158,658,441      
Direct Value   $43,029,120    

Indirect Value

   $12,788,968,670      
Total Shares   159,267,159      
Total Value   $12,831,997,790      


Incyte Corp $32,360,262 Synageva BioPharma Corp $0 Mirati Therapeutics, Inc. $16,084 Seagen Inc $10,649,448 Neurogene $3,327 Incyte Corp $32,360,262 Synageva BioPharma Corp $0 Mirati Therapeutics, Inc. $16,084 Seagen Inc $10,649,448 Neurogene $3,327
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -75.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Genomic Health Inc GHDX Director, 10% Owner 2013-07-01 0 2019-02-27 9,235,362    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2014-03-05 0 2016-04-01 41,897,946    Premium*  
            Incyte Corp INCY Director, 10% Owner 2021-05-14 559,963 2021-05-14 29,367,926    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2014-05-22 0 2014-05-22 518,849    Premium*  
            Aceragen, Inc ACGN Director 2014-07-01 0 2016-01-04 78,885    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-01-07 1,020 2015-01-07 11,877,394    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2016-06-09 274 2016-06-09 30,003    Premium*  
            Intellia Therapeutics, Inc. NTLA Former 10% owner 2016-05-11 0 2016-05-11 976,214    Premium*  
            Invitae Corp NVTA 10% Owner 2016-11-17 0 2016-11-17 6,554,039    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2017-03-24 0 2023-11-22 2,168,818    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2023-05-31 46,557 2023-05-31 42,977,301    Premium*  
            Neurogene NGNE Director, 10% Owner 2023-10-05 904 2023-10-05 1,658,190    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 2022-05-16 0 2022-06-06 4,501,658    Premium*  
            Atreca Inc BCEL Former 10% Owner 2023-10-19 0 2023-10-19 2,971,128    Premium*  
            Igm Biosciences, Inc. IGMS 2023-12-13 0 2024-03-29 3,755,474    Premium*  
            Vtv Therapeutics Inc. VTVT 2024-03-05 0 2024-03-05 89,254    Premium*  
* Premium Members only  

Records found :    103         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
INCY Incyte Corp Director   –       •       •   2016-09-30 4 A $94.29 $56,857 I/I 603 533,720 0 -
NVTA Invitae Corp 10% Owner   –       –       •   2016-11-17 4 B $6.00 $4,399,998 I/I 733,333 6,480,668 1.5 -
INCY Incyte Corp Director   –       •       •   2017-02-17 4 A $0.00 $0 I/I 10,610,782 767,095 0 -
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2017-03-24 4 B $12.00 $1,999,992 I/I 166,666 4,527,089 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2018-04-01 4 A $31.29 $119,778 I/I 3,828 339,585 0 -
GHDX Genomic Health Inc Director   –       •       •   2018-11-16 4 S $76.35 $6,699,000 I/I (87,395) 10,672,645 0 -
GHDX Genomic Health Inc Director   –       •       •   2018-11-26 4 S $74.05 $2,947,113 I/I (39,675) 10,639,954 0 -
GHDX Genomic Health Inc Director   –       •       •   2018-11-27 4 S $73.76 $10,269,089 I/I (138,610) 10,525,744 0 -
GHDX Genomic Health Inc Director   –       •       •   2019-01-23 4 S $70.52 $2,651,092 I/I (37,512) 9,272,021 0 -
GHDX Genomic Health Inc Director   –       •       •   2019-01-24 4 S $72.02 $5,718,588 I/I (79,403) 9,206,595 0 -
GHDX Genomic Health Inc Director   –       •       •   2019-01-25 4 S $72.20 $6,636,648 I/I (91,916) 9,130,859 0 -
GHDX Genomic Health Inc Director   –       •       •   2019-01-28 4 S $70.55 $3,302,980 I/I (46,477) 9,092,565 0 -
GHDX Genomic Health Inc Director   –       •       •   2019-02-26 4 S $77.81 $675,614 I/I (8,650) 9,093,689 0 -
GHDX Genomic Health Inc Director   –       •       •   2019-02-26 4 OE $17.59 $290,235 I/I 16,500 9,100,815 0 -
INCY Incyte Corp Director   –       •       •   2019-02-26 4 OE $2.80 $112,000 I/I 40,000 29,288,793 0 -
GHDX Genomic Health Inc Director   –       •       •   2019-02-27 4 S $76.20 $2,997,792 I/I (39,109) 9,061,465 0 -
SGEN Seagen Inc Director   –       •       •   2019-06-06 4 D $0.00 $0 I/I (1,002,483) 4,302,354 0 -
SGEN Seagen Inc Director   –       •       •   2019-06-06 4 A $0.00 $0 D/D 148,458 181,733 0 -
NGNE Neurogene Director   –       •      –    2019-12-20 4 B $8.40 $25,347,353 I/I 3,017,542 12,872,664 2.1 -
NGNE Neurogene Director   –       •      –    2019-12-20 4 D $0.00 $0 I/I (10,925,481) 3,107,331 0 -
INCY Incyte Corp Director   –       •       •   2021-05-14 4 OE $18.97 $758,800 I/I 40,000 29,334,516 0 -
SGEN Seagen Inc Director   –       •       •   2022-03-08 4 OE $20.06 $702,100 I/I 35,000 42,965,004 0 -
SGEN Seagen Inc Director   –       •       •   2022-05-13 4 A $0.00 $0 I/I 3,006 42,966,507 0 -
TRDA Entrada Therapeutics, Inc... 10% Owner   –       –       •   2022-05-16 4 B $5.83 $110,692 I/I 19,000 4,374,493 1.5 -
TRDA Entrada Therapeutics, Inc... 10% Owner   –       –       •   2022-05-17 4 B $6.13 $113,474 I/I 18,511 4,390,994 1.5 -
  103  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us